Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:B02AB01
|
| gptkbp:CASNumber |
gptkb:9087-70-1
|
| gptkbp:genericName |
gptkb:aprotinin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Trasylol
|
| gptkbp:indication |
cardiac surgery
|
| gptkbp:legalStatus |
withdrawn in US and EU
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:mechanismOfAction |
gptkb:serine_protease
|
| gptkbp:proteinOrigin |
bovine lung
|
| gptkbp:PubChem_CID |
gptkb:DB02381
none |
| gptkbp:retired |
safety concerns
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
myocardial infarction
anaphylaxis renal dysfunction |
| gptkbp:UNII |
93497U5J2J
|
| gptkbp:usedFor |
reducing blood loss during surgery
|
| gptkbp:withdrawn |
2007
|
| gptkbp:bfsParent |
gptkb:Bayer_HealthCare
|
| gptkbp:bfsLayer |
6
|